Trial Profile
A PHASE III TRIAL OF RADIATION THERAPY WITH OR WITHOUT CASODEX IN PATIENTS WITH PSA ELEVATION FOLLOWING RADICAL PROSTATECTOMY FOR pT3N0 CARCINOMA OF THE PROSTATE
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 11 Mar 2024
Price :
$35
*
At a glance
- Drugs Bicalutamide (Primary)
- Indications Carcinoma; Prostate cancer
- Focus Therapeutic Use
- 27 Jan 2024 Primary endpoint has been met. (Overall Survival (12-year Rates Reported))
- 27 Jan 2024 Long-term results of radiation with or without anti-androgens (AAT) in patients receiving salvage prostate bed radiation therapy (sRT) post prostatectomy,resented at the 2024 Genitourinary Cancers Symposium
- 23 May 2022 Status changed from active, no longer recruiting to completed.